Vahldiek, Anna
Heine, Lukas
Vahldiek, Benja
Schröter, Jasper
Wolf, Jan-Niklas
Swora, Michael
Reissberg, Lars
Pauleikhoff, Laurenz
Kleesiek, Jens
Pauleikhoff, Daniel https://orcid.org/0000-0003-3691-291X
Funding for this research was provided by:
Universitätsklinikum Essen
Article History
Received: 19 August 2025
Revised: 30 September 2025
Accepted: 14 October 2025
First Online: 17 November 2025
Change Date: 26 November 2025
Change Type: Update
Change Details: After the paper has been published online, the corresponding author noticed that the images of Figures 1, 5 and 6 are blurry and requested it to be replaced. The figures have now been replaced with the new one.
Declarations
:
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the Institutional Ethics committee of the Institutional Doctors Association Westfalen Lippe, Münster, Germany (file number 2017–033-f-S) and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
: Informed consent was obtained from all individual participants included in the study.
: Anna Vahldiek, Lukas Heine, Benja Vahldiek, Jasper Schröter, Jan-Niklas Wolf, Michael Swora, Lars Reissberg, and J. Kleesiek report no financial disclosures.Laurenz Pauleikhoff reports consultancy with Bayer. Daniel Pauleikhoff reports consultancy with Bayer, Novartis, Heidelberg Engineering, and Roche.